| West Virginia Oncology Society |
ASCO continues to support removing prompt pay discounts from the ASP calculation. We are
currently working to seek co-sponsors for H.R. 1392 and S. 1221 in order to ensure community
oncology practices are able to provide patients with quality cancer care. Prompt-pay discounts
threaten oncology practices by artificially lowering the reimbursement rate for chemotherapy
treatments, resulting in some cases to reduced patient access to treatment.
It is crucial that you let your member of Congress and Senator know the effect the prompt-pay
discount has on your practice and patients. Contact your Senators and your Representative and
urge them to cosponsor this legislation. Helpful hints and talking points on the bill are also
available at ASCO's Grassroots Action Center.
currently working to seek co-sponsors for H.R. 1392 and S. 1221 in order to ensure community
oncology practices are able to provide patients with quality cancer care. Prompt-pay discounts
threaten oncology practices by artificially lowering the reimbursement rate for chemotherapy
treatments, resulting in some cases to reduced patient access to treatment.
It is crucial that you let your member of Congress and Senator know the effect the prompt-pay
discount has on your practice and patients. Contact your Senators and your Representative and
urge them to cosponsor this legislation. Helpful hints and talking points on the bill are also
available at ASCO's Grassroots Action Center.
| Update on Status of Prompt-Pay Discount |
American Society of Clinical Oncology (ASCO)